HOXA11 and ovarian cancer: In conclusion, we found that the expression of HOXA11-AS was up-regulated in ovarian cancer tissues and cisplatin-resistant cells, and HOXA11-AS expression increase was predictive of a poor prognosis (log-rank P = 0.00089).